Although previous studies have demonstrated the critical role of PAI-1 in glucose metabolism dysregulation and diabetes progression, the potential of PAI-1 inhibitors in regulating lipid metabolism in diabetes remains largely unexplored. Here, SERPINE1 is linked to diabetes mellitus.